Drug intelligence / Profile preview

Pentavit

Development stage: Unknown
Lead developer: Triman
Modality: Small Molecules
Administration: Oral

Overview

Pentavit is a multivitamin and mineral dietary supplement developed and manufactured by the Indonesian pharmaceutical company Triman. It is formulated as an oral capsule containing Vitamin C (600 mg as Calcium Ascorbate), Vitamin E (25 IU as dl-alpha tocopheryl acetate), Zinc Picolinate (30 mg), Vitamin D3 (100 IU as Cholecalciferol), and Selenium (20 mcg). The product is indicated for nutritional supplementation to support immune system health and general wellness maintenance. It is registered in Indonesia under the registration number POM SD211380121 and is typically recommended for once-daily administration.

Brand names: Pentavit

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Pentavit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pentavit.

Explore the full profile